| sodium channel, voltage-gated, type II, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 gamma | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type XI, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, gamma | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, delta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, nonvoltage-gated 1 alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type X, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IX, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage gated, type VIII, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VII, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IV, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel associated protein 1 | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel associated protein 2 | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type I, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type IX, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type VII, alpha | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | amiloride-sensitive cation channel 5, intestinal | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | sodium channel, voltage-gated, type III, beta | 
                FLAVOXATE | 
                Sodium Channel, Site 2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cannabinoid receptor 1 (brain) | 
                TOLNAFTATE | 
                Cannabinoid CB1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D1A | 
                SULINDAC SULFIDE | 
                Dopamine D1 | 
                50% | 
                27.822uM | 
                13.911uM | 
              
              
                View
               | 
              
            
          
            
                | mu-opioid receptor MOR | 
                SULINDAC SULFIDE | 
                Opiate mu | 
                50% | 
                33.668uM | 
                13.667uM | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4A, cAMP specific | 
                GENTIAN VIOLET | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4C, cAMP-specific | 
                GENTIAN VIOLET | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4D | 
                GENTIAN VIOLET | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4B, cAMP specific | 
                GENTIAN VIOLET | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 
                GENTIAN VIOLET | 
                Protein Tyrosine Kinase, HER2 Receptor | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 
                GENTIAN VIOLET | 
                Protein Tyrosine Kinase, HER2 Receptor | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                MOSAPRIDE | 
                Calcium Channel Type L, Phenylalkylamine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen activated protein kinase 1 | 
                VALSARTAN | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen-activated protein kinase 1 | 
                VALSARTAN | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 
                QUETIAPINE | 
                Adrenergic, Norepinephrine Transporter | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | 
                TERBINAFINE | 
                Calcium Channel Type L, Dihydropyridine | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | progesterone receptor | 
                NELFINAVIR | 
                Progesterone | 
                50% | 
                44.5uM | 
                5.804uM | 
              
              
                View
               | 
              
            
          
            
                | progesterone receptor | 
                NELFINAVIR | 
                Progesterone | 
                50% | 
                44.5uM | 
                5.804uM | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 5B | 
                TERCONAZOLE | 
                Serotonin 5-HT4 | 
                50% | 
                14.78uM | 
                2.463uM | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 4 | 
                TERCONAZOLE | 
                Serotonin 5-HT4 | 
                50% | 
                14.78uM | 
                2.463uM | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                PROCAINE | 
                Monoamine Oxidase MAOA | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | monoamine oxidase A | 
                PROCAINE | 
                Monoamine Oxidase MAOA | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 
                TACRINE | 
                Dopamine Transporter | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | endothelin receptor type A | 
                SULFISOXAZOLE | 
                Endothelin ETA | 
                50% | 
                21.88uM | 
                13.465uM | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 2 | 
                ROSIGLITAZONE | 
                Muscarinic M2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-1A2 monooxygenase | 
                GLYPHOSATE | 
                CYP450-1A2 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase (YT blood group) | 
                PERGOLIDE | 
                Acetylcholinesterase | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | 
                PERGOLIDE | 
                Acetylcholinesterase | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | acetylcholinesterase | 
                PERGOLIDE | 
                Acetylcholinesterase | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2D6 monooxygenase | 
                CYPROHEPTADINE | 
                CYP450-2D6 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adenosine A2a receptor | 
                ALBENDAZOLE | 
                Adenosine A2A | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Sigma-2 Receptor | 
                SULCONAZOLE | 
                Sigma2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, gamma 1 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, pi | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | AT hook, DNA binding motif, containing 1 (DBSS) | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, theta | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, gamma 2 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, alpha 2 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, alpha 1 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid A receptor, delta | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 | 
                DANAZOL | 
                GABAA, Benzodiazepine, Central | 
                50% | 
                54.326uM | 
                44.266uM | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor 2 | 
                AMLODIPINE | 
                Dopamine D2L | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2A6 monooxygenase | 
                CLOTRIMAZOLE | 
                CYP450-2A6 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                OMEPRAZOLE | 
                CYP450-2C19 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                1-BENZYLIMIDAZOLE | 
                CYP450-2C19 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-1A2 monooxygenase | 
                RO 20-1724 | 
                CYP450-1A2 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 1 | 
                ERGONOVINE | 
                Adrenergic beta1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic, beta-1-, receptor | 
                ERGONOVINE | 
                Adrenergic beta1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | epidermal growth factor receptor | 
                CLOMIPRAMINE | 
                Protein Tyrosine Kinase, EGF Receptor | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | melanocortin 4 receptor | 
                BENZOTHIAZYL DISULFIDE | 
                Melanocortin MC4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | opioid receptor, delta 1 | 
                FLUPHENAZINE | 
                Opiate delta | 
                50% | 
                24.036uM | 
                8.473uM | 
              
              
                View
               | 
              
            
          
            
                | arachidonate 15-lipoxygenase, second type | 
                CAFFEIC ACID PHENETHYL ESTER | 
                Lipoxygenase 15-LO | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 4 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Muscarinic M4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, beta 2 | 
                BW-723C86 | 
                Adrenergic beta2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adrenergic receptor, alpha 2a | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Adrenergic alpha2A | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | bradykinin receptor, beta 2 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Bradykinin B2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | bradykinin receptor B2 | 
                TRANS-PLATINUM(II)DIAMMINE DICHLORIDE | 
                Bradykinin B2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D3 | 
                3,3',5-TRIIODO-L-THYRONINE | 
                Dopamine D3 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1 | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 3, apoptosis related cysteine protease | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 2 | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 7 | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 6 | 
                HEXACHLOROPHENE | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | 
                1,3-DIPHENYLGUANIDINE | 
                Serotonin 5-HT2A | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen activated protein kinase 1 | 
                GLYBURIDE | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen-activated protein kinase 1 | 
                GLYBURIDE | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4A, cAMP specific | 
                ZAFIRLUKAST | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4C, cAMP-specific | 
                ZAFIRLUKAST | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4D | 
                ZAFIRLUKAST | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | phosphodiesterase 4B, cAMP specific | 
                ZAFIRLUKAST | 
                Phosphodiesterase PDE4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | histamine receptor H 2 | 
                DIMENHYDRINATE | 
                Histamine H2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D3 | 
                METHAPYRILENE | 
                Dopamine D3 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D1A | 
                EPINEPHRINE | 
                Dopamine D1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                ERGOCORNINE | 
                CYP450-2C9 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                ERGOCORNINE | 
                CYP450-2C9 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | 
                LOPERAMIDE | 
                CYP450-2C9 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | 
                LOPERAMIDE | 
                CYP450-2C9 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                CANDESARTAN | 
                CYP450-2C19 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Cytochrom P450-2C19 monooxygenase | 
                NANDROLONE | 
                CYP450-2C19 Inhibition | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | adenosine A2a receptor | 
                4-NONYLPHENOL | 
                Adenosine A2A | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | glutamate receptor, ionotropic, NMDA2C | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | glutamate receptor, ionotropic, N-methyl-D-aspartate 3B | 
                TEICOPLANIN | 
                Glutamate, NMDA, Agonism | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 1 | 
                ACEMETACIN | 
                Cyclooxygenase COX-1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 
                ACEMETACIN | 
                Cyclooxygenase COX-1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cathepsin G | 
                RIFAPENTINE | 
                Protease, Cathepsin G | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mast cell protease 9 | 
                RIFAPENTINE | 
                Protease, Cathepsin G | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | 
                TENIDAP | 
                Serotonin 5-HT2B | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen activated protein kinase 1 | 
                ACEMETACIN | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | mitogen-activated protein kinase 1 | 
                ACEMETACIN | 
                Protein Serine/Threonine Kinase, ERK2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1 | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 3, apoptosis related cysteine protease | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 2 | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 7 | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 6 | 
                DACTINOMYCIN | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1 | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 3, apoptosis related cysteine protease | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 2 | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 7 | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | caspase 6 | 
                CLOSANTEL | 
                Protease, Caspase 1 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 
                CLOSANTEL | 
                Adrenergic, Norepinephrine Transporter | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | cholinergic receptor, muscarinic 5 | 
                GRAMICIDIN | 
                Muscarinic M5 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | dopamine receptor D4 | 
                METHYLERGONOVINE | 
                Dopamine D4.2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | 
                DOBUTAMINE | 
                Serotonin 5-HT2A | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | neuropeptide Y receptor Y2 | 
                GRAMICIDIN | 
                Neuropeptide Y2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | neuropeptide Y receptor Y2 | 
                GRAMICIDIN | 
                Neuropeptide Y2 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | lymphocyte protein tyrosine kinase (mapped) | 
                ABAMECTIN | 
                Protein Tyrosine Kinase, Lck | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 5B | 
                LISURIDE | 
                Serotonin 5-HT4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | 5-hydroxytryptamine (serotonin) receptor 4 | 
                LISURIDE | 
                Serotonin 5-HT4 | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | androgen receptor | 
                IVERMECTIN | 
                Testosterone | 
                50% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | Sigma-2 Receptor | 
                S-(-)-PROPRANOLOL | 
                Sigma2 | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               | 
              
            
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | 
                SAQUINAVIR | 
                Calcium Channel Type L, Dihydropyridine | 
                49% | 
                NoneNone | 
                NoneNone | 
              
              
                View
               |